Global Haemophilus b Conjugate Vaccine (Hib) Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Haemophilus b Conjugate Vaccine (Hib) Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Haemophilus b Conjugate Vaccine (Hib) by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Haemophilus b Conjugate Vaccine (Hib) by Country/Region, 2017, 2022 & 2028

2.2 Haemophilus b Conjugate Vaccine (Hib) Segment by Type

2.2.1 Inactivated Vaccine

2.2.2 Live Attenuated Vaccine

2.3 Haemophilus b Conjugate Vaccine (Hib) Sales by Type

2.3.1 Global Haemophilus b Conjugate Vaccine (Hib) Sales Market Share by Type (2017-2022)

2.3.2 Global Haemophilus b Conjugate Vaccine (Hib) Revenue and Market Share by Type (2017-2022)

2.3.3 Global Haemophilus b Conjugate Vaccine (Hib) Sale Price by Type (2017-2022)

2.4 Haemophilus b Conjugate Vaccine (Hib) Segment by Application

2.4.1 Government Institution

2.4.2 Private Sector

2.4.3 Other

2.5 Haemophilus b Conjugate Vaccine (Hib) Sales by Application

2.5.1 Global Haemophilus b Conjugate Vaccine (Hib) Sale Market Share by Application (2017-2022)

2.5.2 Global Haemophilus b Conjugate Vaccine (Hib) Revenue and Market Share by Application (2017-2022)

2.5.3 Global Haemophilus b Conjugate Vaccine (Hib) Sale Price by Application (2017-2022)

3 Global Haemophilus b Conjugate Vaccine (Hib) by Company

3.1 Global Haemophilus b Conjugate Vaccine (Hib) Breakdown Data by Company

3.1.1 Global Haemophilus b Conjugate Vaccine (Hib) Annual Sales by Company (2020-2022)

3.1.2 Global Haemophilus b Conjugate Vaccine (Hib) Sales Market Share by Company (2020-2022)

3.2 Global Haemophilus b Conjugate Vaccine (Hib) Annual Revenue by Company (2020-2022)

3.2.1 Global Haemophilus b Conjugate Vaccine (Hib) Revenue by Company (2020-2022)

3.2.2 Global Haemophilus b Conjugate Vaccine (Hib) Revenue Market Share by Company (2020-2022)

3.3 Global Haemophilus b Conjugate Vaccine (Hib) Sale Price by Company

3.4 Key Manufacturers Haemophilus b Conjugate Vaccine (Hib) Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Haemophilus b Conjugate Vaccine (Hib) Product Location Distribution

3.4.2 Players Haemophilus b Conjugate Vaccine (Hib) Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Haemophilus b Conjugate Vaccine (Hib) by Geographic Region

4.1 World Historic Haemophilus b Conjugate Vaccine (Hib) Market Size by Geographic Region (2017-2022)

4.1.1 Global Haemophilus b Conjugate Vaccine (Hib) Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Haemophilus b Conjugate Vaccine (Hib) Annual Revenue by Geographic Region

4.2 World Historic Haemophilus b Conjugate Vaccine (Hib) Market Size by Country/Region (2017-2022)

4.2.1 Global Haemophilus b Conjugate Vaccine (Hib) Annual Sales by Country/Region (2017-2022)

4.2.2 Global Haemophilus b Conjugate Vaccine (Hib) Annual Revenue by Country/Region

4.3 Americas Haemophilus b Conjugate Vaccine (Hib) Sales Growth

4.4 APAC Haemophilus b Conjugate Vaccine (Hib) Sales Growth

4.5 Europe Haemophilus b Conjugate Vaccine (Hib) Sales Growth

4.6 Middle East & Africa Haemophilus b Conjugate Vaccine (Hib) Sales Growth

5 Americas

5.1 Americas Haemophilus b Conjugate Vaccine (Hib) Sales by Country

5.1.1 Americas Haemophilus b Conjugate Vaccine (Hib) Sales by Country (2017-2022)

5.1.2 Americas Haemophilus b Conjugate Vaccine (Hib) Revenue by Country (2017-2022)

5.2 Americas Haemophilus b Conjugate Vaccine (Hib) Sales by Type

5.3 Americas Haemophilus b Conjugate Vaccine (Hib) Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Haemophilus b Conjugate Vaccine (Hib) Sales by Region

6.1.1 APAC Haemophilus b Conjugate Vaccine (Hib) Sales by Region (2017-2022)

6.1.2 APAC Haemophilus b Conjugate Vaccine (Hib) Revenue by Region (2017-2022)

6.2 APAC Haemophilus b Conjugate Vaccine (Hib) Sales by Type

6.3 APAC Haemophilus b Conjugate Vaccine (Hib) Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Haemophilus b Conjugate Vaccine (Hib) by Country

7.1.1 Europe Haemophilus b Conjugate Vaccine (Hib) Sales by Country (2017-2022)

7.1.2 Europe Haemophilus b Conjugate Vaccine (Hib) Revenue by Country (2017-2022)

7.2 Europe Haemophilus b Conjugate Vaccine (Hib) Sales by Type

7.3 Europe Haemophilus b Conjugate Vaccine (Hib) Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Haemophilus b Conjugate Vaccine (Hib) by Country

8.1.1 Middle East & Africa Haemophilus b Conjugate Vaccine (Hib) Sales by Country (2017-2022)

8.1.2 Middle East & Africa Haemophilus b Conjugate Vaccine (Hib) Revenue by Country (2017-2022)

8.2 Middle East & Africa Haemophilus b Conjugate Vaccine (Hib) Sales by Type

8.3 Middle East & Africa Haemophilus b Conjugate Vaccine (Hib) Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Haemophilus b Conjugate Vaccine (Hib)

10.3 Manufacturing Process Analysis of Haemophilus b Conjugate Vaccine (Hib)

10.4 Industry Chain Structure of Haemophilus b Conjugate Vaccine (Hib)

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Haemophilus b Conjugate Vaccine (Hib) Distributors

11.3 Haemophilus b Conjugate Vaccine (Hib) Customer

12 World Forecast Review for Haemophilus b Conjugate Vaccine (Hib) by Geographic Region

12.1 Global Haemophilus b Conjugate Vaccine (Hib) Market Size Forecast by Region

12.1.1 Global Haemophilus b Conjugate Vaccine (Hib) Forecast by Region (2023-2028)

12.1.2 Global Haemophilus b Conjugate Vaccine (Hib) Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Haemophilus b Conjugate Vaccine (Hib) Forecast by Type

12.7 Global Haemophilus b Conjugate Vaccine (Hib) Forecast by Application

13 Key Players Analysis

13.1 Sanofi Pasteur, SA

13.1.1 Sanofi Pasteur, SA Company Information

13.1.2 Sanofi Pasteur, SA Haemophilus b Conjugate Vaccine (Hib) Product Offered

13.1.3 Sanofi Pasteur, SA Haemophilus b Conjugate Vaccine (Hib) Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Sanofi Pasteur, SA Main Business Overview

13.1.5 Sanofi Pasteur, SA Latest Developments

13.2 GSK

13.2.1 GSK Company Information

13.2.2 GSK Haemophilus b Conjugate Vaccine (Hib) Product Offered

13.2.3 GSK Haemophilus b Conjugate Vaccine (Hib) Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 GSK Main Business Overview

13.2.5 GSK Latest Developments

13.3 Merck

13.3.1 Merck Company Information

13.3.2 Merck Haemophilus b Conjugate Vaccine (Hib) Product Offered

13.3.3 Merck Haemophilus b Conjugate Vaccine (Hib) Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Merck Main Business Overview

13.3.5 Merck Latest Developments

14 Research Findings and Conclusion

Table 1. Haemophilus b Conjugate Vaccine (Hib) Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Haemophilus b Conjugate Vaccine (Hib) Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Inactivated Vaccine

Table 4. Major Players of Live Attenuated Vaccine

Table 5. Global Haemophilus b Conjugate Vaccine (Hib) Sales by Type (2017-2022) & (K Doses)

Table 6. Global Haemophilus b Conjugate Vaccine (Hib) Sales Market Share by Type (2017-2022)

Table 7. Global Haemophilus b Conjugate Vaccine (Hib) Revenue by Type (2017-2022) & ($ million)

Table 8. Global Haemophilus b Conjugate Vaccine (Hib) Revenue Market Share by Type (2017-2022)

Table 9. Global Haemophilus b Conjugate Vaccine (Hib) Sale Price by Type (2017-2022) & (US$/Dose)

Table 10. Global Haemophilus b Conjugate Vaccine (Hib) Sales by Application (2017-2022) & (K Doses)

Table 11. Global Haemophilus b Conjugate Vaccine (Hib) Sales Market Share by Application (2017-2022)

Table 12. Global Haemophilus b Conjugate Vaccine (Hib) Revenue by Application (2017-2022)

Table 13. Global Haemophilus b Conjugate Vaccine (Hib) Revenue Market Share by Application (2017-2022)

Table 14. Global Haemophilus b Conjugate Vaccine (Hib) Sale Price by Application (2017-2022) & (US$/Dose)

Table 15. Global Haemophilus b Conjugate Vaccine (Hib) Sales by Company (2020-2022) & (K Doses)

Table 16. Global Haemophilus b Conjugate Vaccine (Hib) Sales Market Share by Company (2020-2022)

Table 17. Global Haemophilus b Conjugate Vaccine (Hib) Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Haemophilus b Conjugate Vaccine (Hib) Revenue Market Share by Company (2020-2022)

Table 19. Global Haemophilus b Conjugate Vaccine (Hib) Sale Price by Company (2020-2022) & (US$/Dose)

Table 20. Key Manufacturers Haemophilus b Conjugate Vaccine (Hib) Producing Area Distribution and Sales Area

Table 21. Players Haemophilus b Conjugate Vaccine (Hib) Products Offered

Table 22. Haemophilus b Conjugate Vaccine (Hib) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Haemophilus b Conjugate Vaccine (Hib) Sales by Geographic Region (2017-2022) & (K Doses)

Table 26. Global Haemophilus b Conjugate Vaccine (Hib) Sales Market Share Geographic Region (2017-2022)

Table 27. Global Haemophilus b Conjugate Vaccine (Hib) Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Haemophilus b Conjugate Vaccine (Hib) Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Haemophilus b Conjugate Vaccine (Hib) Sales by Country/Region (2017-2022) & (K Doses)

Table 30. Global Haemophilus b Conjugate Vaccine (Hib) Sales Market Share by Country/Region (2017-2022)

Table 31. Global Haemophilus b Conjugate Vaccine (Hib) Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Haemophilus b Conjugate Vaccine (Hib) Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Haemophilus b Conjugate Vaccine (Hib) Sales by Country (2017-2022) & (K Doses)

Table 34. Americas Haemophilus b Conjugate Vaccine (Hib) Sales Market Share by Country (2017-2022)

Table 35. Americas Haemophilus b Conjugate Vaccine (Hib) Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Haemophilus b Conjugate Vaccine (Hib) Revenue Market Share by Country (2017-2022)

Table 37. Americas Haemophilus b Conjugate Vaccine (Hib) Sales by Type (2017-2022) & (K Doses)

Table 38. Americas Haemophilus b Conjugate Vaccine (Hib) Sales Market Share by Type (2017-2022)

Table 39. Americas Haemophilus b Conjugate Vaccine (Hib) Sales by Application (2017-2022) & (K Doses)

Table 40. Americas Haemophilus b Conjugate Vaccine (Hib) Sales Market Share by Application (2017-2022)

Table 41. APAC Haemophilus b Conjugate Vaccine (Hib) Sales by Region (2017-2022) & (K Doses)

Table 42. APAC Haemophilus b Conjugate Vaccine (Hib) Sales Market Share by Region (2017-2022)

Table 43. APAC Haemophilus b Conjugate Vaccine (Hib) Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Haemophilus b Conjugate Vaccine (Hib) Revenue Market Share by Region (2017-2022)

Table 45. APAC Haemophilus b Conjugate Vaccine (Hib) Sales by Type (2017-2022) & (K Doses)

Table 46. APAC Haemophilus b Conjugate Vaccine (Hib) Sales Market Share by Type (2017-2022)

Table 47. APAC Haemophilus b Conjugate Vaccine (Hib) Sales by Application (2017-2022) & (K Doses)

Table 48. APAC Haemophilus b Conjugate Vaccine (Hib) Sales Market Share by Application (2017-2022)

Table 49. Europe Haemophilus b Conjugate Vaccine (Hib) Sales by Country (2017-2022) & (K Doses)

Table 50. Europe Haemophilus b Conjugate Vaccine (Hib) Sales Market Share by Country (2017-2022)

Table 51. Europe Haemophilus b Conjugate Vaccine (Hib) Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Haemophilus b Conjugate Vaccine (Hib) Revenue Market Share by Country (2017-2022)

Table 53. Europe Haemophilus b Conjugate Vaccine (Hib) Sales by Type (2017-2022) & (K Doses)

Table 54. Europe Haemophilus b Conjugate Vaccine (Hib) Sales Market Share by Type (2017-2022)

Table 55. Europe Haemophilus b Conjugate Vaccine (Hib) Sales by Application (2017-2022) & (K Doses)

Table 56. Europe Haemophilus b Conjugate Vaccine (Hib) Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Haemophilus b Conjugate Vaccine (Hib) Sales by Country (2017-2022) & (K Doses)

Table 58. Middle East & Africa Haemophilus b Conjugate Vaccine (Hib) Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Haemophilus b Conjugate Vaccine (Hib) Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Haemophilus b Conjugate Vaccine (Hib) Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Haemophilus b Conjugate Vaccine (Hib) Sales by Type (2017-2022) & (K Doses)

Table 62. Middle East & Africa Haemophilus b Conjugate Vaccine (Hib) Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Haemophilus b Conjugate Vaccine (Hib) Sales by Application (2017-2022) & (K Doses)

Table 64. Middle East & Africa Haemophilus b Conjugate Vaccine (Hib) Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Haemophilus b Conjugate Vaccine (Hib)

Table 66. Key Market Challenges & Risks of Haemophilus b Conjugate Vaccine (Hib)

Table 67. Key Industry Trends of Haemophilus b Conjugate Vaccine (Hib)

Table 68. Haemophilus b Conjugate Vaccine (Hib) Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Haemophilus b Conjugate Vaccine (Hib) Distributors List

Table 71. Haemophilus b Conjugate Vaccine (Hib) Customer List

Table 72. Global Haemophilus b Conjugate Vaccine (Hib) Sales Forecast by Region (2023-2028) & (K Doses)

Table 73. Global Haemophilus b Conjugate Vaccine (Hib) Sales Market Forecast by Region

Table 74. Global Haemophilus b Conjugate Vaccine (Hib) Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Haemophilus b Conjugate Vaccine (Hib) Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Haemophilus b Conjugate Vaccine (Hib) Sales Forecast by Country (2023-2028) & (K Doses)

Table 77. Americas Haemophilus b Conjugate Vaccine (Hib) Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Haemophilus b Conjugate Vaccine (Hib) Sales Forecast by Region (2023-2028) & (K Doses)

Table 79. APAC Haemophilus b Conjugate Vaccine (Hib) Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Haemophilus b Conjugate Vaccine (Hib) Sales Forecast by Country (2023-2028) & (K Doses)

Table 81. Europe Haemophilus b Conjugate Vaccine (Hib) Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Haemophilus b Conjugate Vaccine (Hib) Sales Forecast by Country (2023-2028) & (K Doses)

Table 83. Middle East & Africa Haemophilus b Conjugate Vaccine (Hib) Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Haemophilus b Conjugate Vaccine (Hib) Sales Forecast by Type (2023-2028) & (K Doses)

Table 85. Global Haemophilus b Conjugate Vaccine (Hib) Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Haemophilus b Conjugate Vaccine (Hib) Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Haemophilus b Conjugate Vaccine (Hib) Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Haemophilus b Conjugate Vaccine (Hib) Sales Forecast by Application (2023-2028) & (K Doses)

Table 89. Global Haemophilus b Conjugate Vaccine (Hib) Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Haemophilus b Conjugate Vaccine (Hib) Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Haemophilus b Conjugate Vaccine (Hib) Revenue Market Share Forecast by Application (2023-2028)

Table 92. Sanofi Pasteur, SA Basic Information, Haemophilus b Conjugate Vaccine (Hib) Manufacturing Base, Sales Area and Its Competitors

Table 93. Sanofi Pasteur, SA Haemophilus b Conjugate Vaccine (Hib) Product Offered

Table 94. Sanofi Pasteur, SA Haemophilus b Conjugate Vaccine (Hib) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 95. Sanofi Pasteur, SA Main Business

Table 96. Sanofi Pasteur, SA Latest Developments

Table 97. GSK Basic Information, Haemophilus b Conjugate Vaccine (Hib) Manufacturing Base, Sales Area and Its Competitors

Table 98. GSK Haemophilus b Conjugate Vaccine (Hib) Product Offered

Table 99. GSK Haemophilus b Conjugate Vaccine (Hib) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 100. GSK Main Business

Table 101. GSK Latest Developments

Table 102. Merck Basic Information, Haemophilus b Conjugate Vaccine (Hib) Manufacturing Base, Sales Area and Its Competitors

Table 103. Merck Haemophilus b Conjugate Vaccine (Hib) Product Offered

Table 104. Merck Haemophilus b Conjugate Vaccine (Hib) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 105. Merck Main Business

Table 106. Merck Latest Developments

List of Figures

Figure 1. Picture of Haemophilus b Conjugate Vaccine (Hib)

Figure 2. Haemophilus b Conjugate Vaccine (Hib) Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Haemophilus b Conjugate Vaccine (Hib) Sales Growth Rate 2017-2028 (K Doses)

Figure 7. Global Haemophilus b Conjugate Vaccine (Hib) Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Haemophilus b Conjugate Vaccine (Hib) Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Inactivated Vaccine

Figure 10. Product Picture of Live Attenuated Vaccine

Figure 11. Global Haemophilus b Conjugate Vaccine (Hib) Sales Market Share by Type in 2021

Figure 12. Global Haemophilus b Conjugate Vaccine (Hib) Revenue Market Share by Type (2017-2022)

Figure 13. Haemophilus b Conjugate Vaccine (Hib) Consumed in Government Institution

Figure 14. Global Haemophilus b Conjugate Vaccine (Hib) Market: Government Institution (2017-2022) & (K Doses)

Figure 15. Haemophilus b Conjugate Vaccine (Hib) Consumed in Private Sector

Figure 16. Global Haemophilus b Conjugate Vaccine (Hib) Market: Private Sector (2017-2022) & (K Doses)

Figure 17. Haemophilus b Conjugate Vaccine (Hib) Consumed in Other

Figure 18. Global Haemophilus b Conjugate Vaccine (Hib) Market: Other (2017-2022) & (K Doses)

Figure 19. Global Haemophilus b Conjugate Vaccine (Hib) Sales Market Share by Application (2017-2022)

Figure 20. Global Haemophilus b Conjugate Vaccine (Hib) Revenue Market Share by Application in 2021

Figure 21. Haemophilus b Conjugate Vaccine (Hib) Revenue Market by Company in 2021 ($ Million)

Figure 22. Global Haemophilus b Conjugate Vaccine (Hib) Revenue Market Share by Company in 2021

Figure 23. Global Haemophilus b Conjugate Vaccine (Hib) Sales Market Share by Geographic Region (2017-2022)

Figure 24. Global Haemophilus b Conjugate Vaccine (Hib) Revenue Market Share by Geographic Region in 2021

Figure 25. Global Haemophilus b Conjugate Vaccine (Hib) Sales Market Share by Region (2017-2022)

Figure 26. Global Haemophilus b Conjugate Vaccine (Hib) Revenue Market Share by Country/Region in 2021

Figure 27. Americas Haemophilus b Conjugate Vaccine (Hib) Sales 2017-2022 (K Doses)

Figure 28. Americas Haemophilus b Conjugate Vaccine (Hib) Revenue 2017-2022 ($ Millions)

Figure 29. APAC Haemophilus b Conjugate Vaccine (Hib) Sales 2017-2022 (K Doses)

Figure 30. APAC Haemophilus b Conjugate Vaccine (Hib) Revenue 2017-2022 ($ Millions)

Figure 31. Europe Haemophilus b Conjugate Vaccine (Hib) Sales 2017-2022 (K Doses)

Figure 32. Europe Haemophilus b Conjugate Vaccine (Hib) Revenue 2017-2022 ($ Millions)

Figure 33. Middle East & Africa Haemophilus b Conjugate Vaccine (Hib) Sales 2017-2022 (K Doses)

Figure 34. Middle East & Africa Haemophilus b Conjugate Vaccine (Hib) Revenue 2017-2022 ($ Millions)

Figure 35. Americas Haemophilus b Conjugate Vaccine (Hib) Sales Market Share by Country in 2021

Figure 36. Americas Haemophilus b Conjugate Vaccine (Hib) Revenue Market Share by Country in 2021

Figure 37. United States Haemophilus b Conjugate Vaccine (Hib) Revenue Growth 2017-2022 ($ Millions)

Figure 38. Canada Haemophilus b Conjugate Vaccine (Hib) Revenue Growth 2017-2022 ($ Millions)

Figure 39. Mexico Haemophilus b Conjugate Vaccine (Hib) Revenue Growth 2017-2022 ($ Millions)

Figure 40. Brazil Haemophilus b Conjugate Vaccine (Hib) Revenue Growth 2017-2022 ($ Millions)

Figure 41. APAC Haemophilus b Conjugate Vaccine (Hib) Sales Market Share by Region in 2021

Figure 42. APAC Haemophilus b Conjugate Vaccine (Hib) Revenue Market Share by Regions in 2021

Figure 43. China Haemophilus b Conjugate Vaccine (Hib) Revenue Growth 2017-2022 ($ Millions)

Figure 44. Japan Haemophilus b Conjugate Vaccine (Hib) Revenue Growth 2017-2022 ($ Millions)

Figure 45. South Korea Haemophilus b Conjugate Vaccine (Hib) Revenue Growth 2017-2022 ($ Millions)

Figure 46. Southeast Asia Haemophilus b Conjugate Vaccine (Hib) Revenue Growth 2017-2022 ($ Millions)

Figure 47. India Haemophilus b Conjugate Vaccine (Hib) Revenue Growth 2017-2022 ($ Millions)

Figure 48. Australia Haemophilus b Conjugate Vaccine (Hib) Revenue Growth 2017-2022 ($ Millions)

Figure 49. Europe Haemophilus b Conjugate Vaccine (Hib) Sales Market Share by Country in 2021

Figure 50. Europe Haemophilus b Conjugate Vaccine (Hib) Revenue Market Share by Country in 2021

Figure 51. Germany Haemophilus b Conjugate Vaccine (Hib) Revenue Growth 2017-2022 ($ Millions)

Figure 52. France Haemophilus b Conjugate Vaccine (Hib) Revenue Growth 2017-2022 ($ Millions)

Figure 53. UK Haemophilus b Conjugate Vaccine (Hib) Revenue Growth 2017-2022 ($ Millions)

Figure 54. Italy Haemophilus b Conjugate Vaccine (Hib) Revenue Growth 2017-2022 ($ Millions)

Figure 55. Russia Haemophilus b Conjugate Vaccine (Hib) Revenue Growth 2017-2022 ($ Millions)

Figure 56. Middle East & Africa Haemophilus b Conjugate Vaccine (Hib) Sales Market Share by Country in 2021

Figure 57. Middle East & Africa Haemophilus b Conjugate Vaccine (Hib) Revenue Market Share by Country in 2021

Figure 58. Egypt Haemophilus b Conjugate Vaccine (Hib) Revenue Growth 2017-2022 ($ Millions)

Figure 59. South Africa Haemophilus b Conjugate Vaccine (Hib) Revenue Growth 2017-2022 ($ Millions)

Figure 60. Israel Haemophilus b Conjugate Vaccine (Hib) Revenue Growth 2017-2022 ($ Millions)

Figure 61. Turkey Haemophilus b Conjugate Vaccine (Hib) Revenue Growth 2017-2022 ($ Millions)

Figure 62. GCC Country Haemophilus b Conjugate Vaccine (Hib) Revenue Growth 2017-2022 ($ Millions)

Figure 63. Manufacturing Cost Structure Analysis of Haemophilus b Conjugate Vaccine (Hib) in 2021

Figure 64. Manufacturing Process Analysis of Haemophilus b Conjugate Vaccine (Hib)

Figure 65. Industry Chain Structure of Haemophilus b Conjugate Vaccine (Hib)

Figure 66. Channels of Distribution

Figure 67. Distributors Profiles